
IN BRIEF: ValiRx shares jump on breast cancer drug candidate progress
ValiRx PLC - Nuneaton, England-based drug development company - Completes the evaluation of the impact of a peptide drug candidate against triple negative breast cancer. Evaluation concludes there is...
Read more